Inflammation-associated drug resistance and tumor growth in TNBC

Inflammation-associated drug resistance and tumor growth in TNBC

Triple-negative breast cancer (TNBC) is an aggressive and clinically challenging subtype of breast cancer characterized by the absence of hormone receptors and HER2 amplification. This molecular profile limits the effectiveness of targeted therapies, leaving chemotherapy as the mainstay of treatment...

Full description

Saved in:

Bibliographic Details
Main Authors:	Arij Fouzat Hassan, Hadeel Kheraldine, Lama Abujamous, Hamda Al-Thawadi, Abdelbary Elhissi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Immunology
Subjects:	triple-negative breast cancer (TNBC) tumor microenvironment (TME) inflammation cytokines drug resistance
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1623137/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synergistic inhibition of TNBC by USP33 and TAP63 through autophagy and ferroptosis activation
by: Feilin Qu, et al.
Published: (2025-08-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

GPX3 promotes cisplatin resistance in TNBC by manipulating ROS-TGFB1-ZEB2
by: Qingyi Hu, et al.
Published: (2025-07-01)

MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer
by: Cheng Hyun Lee, et al.
Published: (2025-07-01)

The circDUSP1/miR-429/DLC1 regulatory network affects proliferation, migration, and invasion of triple-negative breast cancer cells
by: Canhui Jian, et al.
Published: (2025-07-01)

Metformin-Based Combination Approaches for Triple-Negative Breast Cancer
by: Zaid Sirhan, et al.
Published: (2025-04-01)

Echinochrome A inhibits epithelial–mesenchymal transition and induces cell death mediated by DNA damage in human triple-negative breast cancer cells
by: Soon Yong Park, et al.
Published: (2025-10-01)

Molecular genetic predictors of progression of triple negative breast cancer
by: I. S. Panchenko, et al.
Published: (2025-03-01)

Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells
by: Benjamin D Landry, et al.
Published: (2018-08-01)

Bioinformatics analysis for immune hub genes in BLIS subtype of triple-negative breast cancer
by: Hend Adel, et al.
Published: (2025-07-01)

Tumor-infiltrating immune cells state-implications for various breast cancer subtypes
by: Tianshuang Xu, et al.
Published: (2025-05-01)

Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC
by: Nasi Liu, et al.
Published: (2025-07-01)

Plant polysaccharides in the regulation of the tumor microenvironment: a review
by: Yuhua Li, et al.
Published: (2025-09-01)

Liquid biopsy in TNBC: significance in diagnostics, prediction, and treatment monitoring
by: Jiayi Sheng, et al.
Published: (2025-08-01)

Therapeutic limitations of oncolytic VSVd51-mediated miR-199a-5p delivery in triple negative breast cancer models
by: Guillaume St-Cyr, et al.
Published: (2025-05-01)

The pivotal role of tertiary lymphoid structures in the tumor immune microenvironment
by: Chengsen Liu, et al.
Published: (2025-05-01)

Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis
by: Shihao Sun, et al.
Published: (2025-08-01)

CCT196969 inhibits TNBC by targeting the HDAC5/RXRA/ASNS axis to down-regulate asparagine synthesis
by: Qiong Yuan, et al.
Published: (2025-08-01)

Central nervous system relapse in triple-negative breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy: A retrospective cohort analysis
by: Gabriel Berlingieri Polho, et al.
Published: (2025-10-01)

Salvianic acid A enhances anti-PD-1 therapy by promoting HEV-mediated stem-like CD8 T cells infiltration in TNBC
by: Xiaoming Ding, et al.
Published: (2025-06-01)

Cohesive data analysis for the identification of prognostic hub genes and significant pathways associated with HER2 + and TN breast cancer types
by: Mahrukh Zakir, et al.
Published: (2025-07-01)

CD24a knockout results in an enhanced macrophage- and CD8⁺ T cell-mediated anti-tumor immune responses in tumor microenvironment in a murine triple-negative breast cancer model
by: Shih-Hsuan Chan, et al.
Published: (2025-08-01)

Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer
by: Chuanzhi Chen, et al.
Published: (2025-06-01)

The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
by: Chikako Funasaka, et al.
Published: (2025-01-01)

Plasma exosomes in insulin resistant obesity exacerbate progression of triple negative breast cancer
by: Pablo Llévenes, et al.
Published: (2025-07-01)

CAFs exosomal circFOXO1 promotes TNBC autophagy and radioresistance via miR-27a-3p/BNIP3 axis
by: Xueqiong Xun, et al.
Published: (2025-08-01)

Blood mononuclear cell molecular landscape associated with tumor progression in triple-negative breast cancer
by: M. R. Patysheva, et al.
Published: (2023-11-01)

HEREDITARY BREAST CANCER
by: E. M. Bit-Sava, et al.
Published: (2016-02-01)

Metaplastic carcinoma of the breast: A case series and review of the literature
by: Deniz Eren Böler, et al.
Published: (2016-08-01)

Effect and clinical mechanism exploration of acupuncture intervention for chemotherapy-related cognitive impairment (CRCI) in triple-negative breast cancer: study protocol for a randomized controlled trial
by: Wenqi Yang, et al.
Published: (2025-07-01)

Amino acids shape the metabolic and immunologic landscape in the tumor immune microenvironment: from molecular mechanisms to therapeutic strategies
by: Ziyou Lin, et al.
Published: (2025-07-01)

SHCBP1 drives tumor progression in triple-negative breast cancer
by: Huiling Wang, et al.
Published: (2025-07-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

PML localization in tumor associated macrophages as a prognostic marker in triple negative breast cancer
by: Bianca Vezzani, et al.
Published: (2025-07-01)

Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study
by: Beate Vajen, et al.
Published: (2025-05-01)

Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
by: Vinod K. Ramani, et al.
Published: (2025-08-01)

Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study
by: Yun-Yi Wang, et al.
Published: (2025-08-01)

Cold-inducible RNA-binding protein is associated with subtype-specific breast cancer patient outcomes
by: Matthew Dankner, et al.
Published: (2025-08-01)

A smart all-in-one strategy based on hybrid bacteria with targeting drug delivery and spatiotemporal drug release to boost the synergistic therapeutic efficacy against TNBC
by: Wenzhe Yuan, et al.
Published: (2025-06-01)

Cytokine release syndrome and CAR T Cell therapy: Modulating the intensity of the inflammatory response and resolution within the tumor microenvironment
by: David F. Driscoll, et al.
Published: (2025-06-01)